10x Genomics, Inc. - Common Stock (NQ:TXG)

94.03 +0.53 (+0.57%)

Delayed Quote Updated: 11:14 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

10x Genomics (TXG) Q4 2025 Earnings Transcript ↗

February 12, 2026

10x Genomics (TXG) Q4 2025 Earnings Transcript

Via The Motley Fool

Topics Intellectual Property

10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025

February 12, 2026

Biotech company 10x Genomics (NASDAQ:TXG) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales were flat year on year at $166 million. The company expects the full year’s...

Via StockStory

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

February 10, 2026

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings this Thursday after market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

1 Momentum Stock to Target This Week and 2 We Turn Down

February 02, 2026

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro...

Via StockStory

3 Small-Cap Stocks We’re Skeptical Of

January 25, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

3 Cash-Producing Stocks That Fall Short

January 22, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

3 Unprofitable Stocks with Warning Signs

January 21, 2026

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Via StockStory

Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest

January 21, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

Via StockStory

Topics Artificial Intelligence

3 Hyped Up Stocks That Concern Us

January 18, 2026

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

1 Healthcare Stock to Consider Right Now and 2 We Find Risky

January 15, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

Via StockStory

Topics Stocks

1 Cash-Heavy Stock to Consider Right Now and 2 We Question

January 12, 2026

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Why 10x Genomics (TXG) Shares Are Falling Today

January 12, 2026

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 4.7% in the afternoon session after the company announced weak preliminary results for its fourth quarter and full year 2025, which pointed to a...

Via StockStory

Topics Intellectual Property

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

January 07, 2026

From CareDx, Inc.

Via Business Wire

10x Genomics (TXG) Stock Is Up, What You Need To Know

January 02, 2026

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.5% in the afternoon session after several analysts raised their price targets on the stock, pointing to a more optimistic outlook for the...

Via StockStory

Topics Artificial Intelligence

2 Russell 2000 Stocks Worth Investigating and 1 We Avoid

January 01, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

10x Genomics (TXG) Stock Trades Up, Here Is Why

December 22, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 4.8% in the morning session after Canaccord Genuity maintained its 'Buy' rating and raised its price target on the company's shares.

Via StockStory

Topics Artificial Intelligence

1 Stock Under $50 Worth Your Attention and 2 We Turn Down

December 21, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

10x Genomics (TXG) Q2 2025 Earnings Transcript ↗

December 11, 2025

10x Genomics (TXG) Q2 2025 Earnings Transcript

Via The Motley Fool

Topics Intellectual Property World Trade

10x Genomics (TXG) Q4 2024 Earnings Transcript ↗

December 11, 2025

10x Genomics (TXG) Q4 2024 Earnings Transcript

Via The Motley Fool

Why 10x Genomics (TXG) Stock Is Nosediving

December 11, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 6.3% in the morning session after Citigroup downgraded the stock to Neutral from Buy.

Via StockStory

Topics Government

Life Sciences Tools & Services Stocks Q3 Earnings: 10x Genomics (NASDAQ:TXG) Firing on All Cylinders

December 07, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how life sciences tools & services stocks fared in Q3, starting...

Via StockStory

Topics Artificial Intelligence

3 Unprofitable Stocks with Questionable Fundamentals

December 03, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

10x Genomics (TXG) Q3 2025 Earnings Transcript ↗

November 27, 2025

10x Genomics (TXG) Q3 2025 Earnings Transcript

Via The Motley Fool

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government...

Via StockStory

Topics Economy Government

Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

3 Reasons to Avoid TXG and 1 Stock to Buy Instead

November 18, 2025

What a time it’s been for 10x Genomics. In the past six months alone, the company’s stock price has increased by a massive 73.9%, reaching $15.53 per share. This was partly thanks to its solid...

Via StockStory

1 Momentum Stock with Promising Prospects and 2 We Avoid

November 13, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

5 Insightful Analyst Questions From 10x Genomics’s Q3 Earnings Call

November 13, 2025

10x Genomics delivered results in Q3 that exceeded Wall Street’s expectations, driven by robust demand in spatial biology and a steady performance in single-cell consumables. Management attributed the...

Via StockStory

Topics Earnings

1 Small-Cap Stock for Long-Term Investors and 2 We Avoid

November 11, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Why 10x Genomics (TXG) Stock Is Trading Up Today

November 11, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 0.6% in the afternoon session after Canaccord Genuity Group raised its price target on the stock. The analyst firm lifted its target to $19.00...

Via StockStory

Topics Artificial Intelligence Supply Chain

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.